The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity

被引：0
|
作者：
Yin, Jun [1 ]
Liu, Yuexing [1 ]
Jia, Weiping [1 ,2 ]
机构：
[1] Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai,200233, China
[2] Institute for Proactive Healthcare, Shanghai Jiao Tong University, Shanghai,200030, China
来源：
Chinese Science Bulletin | 2024年 / 69卷 / 35期
关键词：
D O I：
10.1360/TB-2024-0417
中图分类号：
学科分类号：
摘要：
43
引用
收藏
页码：5094 / 5099
相关论文
共 50 条
  • [31] Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands
    Tanday, Neil
    Flatt, Peter R.
    Irwin, Nigel
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 526 - 541
  • [32] Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
    Mabilleau, Guillaume
    Pereira, Marie
    Chenu, Chantal
    JOURNAL OF ENDOCRINOLOGY, 2018, 236 (01) : R29 - R42
  • [33] Glucagon-like peptide-1 (GLP-1) is a powerful inhibitor of gastric emptying in man
    Näslund, E
    Skogar, S
    Grybäck, P
    Jacobsson, H
    Holst, JJ
    Hellström, PM
    GASTROENTEROLOGY, 1998, 114 (04) : A810 - A810
  • [34] Molecular simulation of zwitterionic polypeptides on protecting glucagon-like peptide-1 (GLP-1)
    Teng, Jiaman
    Liu, Yuting
    Shen, Zhuanglin
    Lv, Weizhong
    Chen, Yantao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 174 : 519 - 526
  • [35] Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum
    U. Ritzel
    A. Fromme
    M. Ottleben
    U. Leonhardt
    G. Ramadori
    Acta Diabetologica, 1997, 34 : 18 - 21
  • [36] Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning
    Basalay, Marina V.
    Mastitskaya, Svetlana
    Mrochek, Aleksander
    Ackland, Gareth L.
    del Arroyo, Ana Gutierrez
    Sanchez, Jenifer
    Sjoquist, Per-Ove
    Pernow, John
    Gourine, Alexander V.
    Gourine, Andrey
    CARDIOVASCULAR RESEARCH, 2016, 112 (03) : 669 - 676
  • [37] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Kastin, AJ
    Akerstrom, V
    Pan, WH
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 18 (1-2) : 7 - 14
  • [38] Gastrointestinal effects of glucagon-like peptide-1 (GLP-1): Mechanism of action.
    Holst, JJ
    Wojdemann, M
    Wettergren, A
    DIABETES, 1996, 45 : 859 - 859
  • [39] Glucagon-like Peptide-1 (GLP-1): 25 Years Incentive for Diabetes research
    Nauck, M. A.
    DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (05) : 367 - 372
  • [40] Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
    Koshal, Prashant
    Jamwal, Sumit
    Kumar, Puneet
    NEUROPHARMACOLOGY, 2018, 136 : 271 - 279
12345